Abstract
5-Substituted 2,4-dimethyl-1,6-dihydropyrimidin-6-ones reacted with aromatic aldehydes to give 5-substituted 2-[(E)-2-arylethenyl]pyrimidin-6-ones, and the reaction of 5-(4-fluorobenzyl)-2,6-dimethylpyrimidin-4(3H)-one with 4-fluorobenzaldehyde produced 5-(4-fluorobenzyl)-2,6-bis[(E)-2-(4-fluorophenyl)ethenyl]pyrimidin-4(3H)-one. Uracil and 5-fluorouracil were alkylated with 2-(chloromethyl)-4-methoxybenzaldehyde, and the resulting 3-[2,4-dioxo- and 5-fluoro-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)methyl]-4-methoxybenzaldehydes were condensed with 5-substituted 2,4-dimethyl-1,6-dihydropyrimidin-6-ones to obtain 1-(5-{(E)-2-[5-(butyl, arylmethyl)-4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]ethenyl}-2-methoxybenzyl)uracil, -5-fluorouracil, and -5-bromouracil. The synthesized compounds were evaluated for their antibacterial, antitumor, and anti-monoaminoxidase activities, and their molecular docking to some biological targets was performed.
CONFLICT OF INTEREST
The authors declare the absence of conflict of interest.
Notes
Hereinafter, primed locants refer to the substituent at position 5 of the pyrimidine ring, and double-primed locants, to the substituent at position 2.
REFERENCES
Tylinska, B., Wiatrak, B., Czyznikowska, Z., Ciesla-Niechwiadowicz, A., Gebarowska, E., and Janickaklos, A., Int. J. Mol. Sci., 2021, vol. 22, article no. 3825. https://doi.org/10.3390/ijms22083825
Harutyunyan, A.A., Panosyan, G.A., Tamazyan, R.A., Aivazyan, A.G., Gukasyan, G.T., and Danagulyan, G.G., Russ. J. Org. Chem., 2018, vol. 54, p. 614. https://doi.org/10.1134/S1070428018040164
Sanduja, M., Gupta, G., and Virmani, T., J. Appl. Pharm. Sci., 2020, vol. 10, p. 129. https://doi.org/10.7324/JAPS.2020.102019
Harutyunyan, A.A., Gukasyan, G.T., Danagulyan, G.G., Panosyan, H.A., Tamazyan, R.A., and Aivazyan, A.G., Russ. J. Org. Chem., 2018, vol. 54, p. 771. https://doi.org/10.1134/S1070428018050160
Li, P., Maier, J.M., Vik, E.C., Yehl, C.J., Dial, B.E., Rickher, A.E., Smith, M.D., Pellechia, P.J., and Shimizu, K.D., Angew. Chem., Int. Ed., 2017, vol. 56, p. 7209. https://doi.org/10.1002/anie.201702950
Hambardzumyan, A.A., Hovsepyan, A.S., Hayrapetyan, H.L., and Chailyan, S.G., Int. J. Pept. Res. Ther., 2021, vol. 27, p. 1597. https://doi.org/10.1007/s10989-021-10194-z
Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., Ge, J., Zheng, L., Zhang, Y., Wang, H., Zhu, Y., Zhu, C., Hu, T., Hua, T., Zhang, B., Yang, X., Li, J., Yang, H., Liu, Z., Xu, W., Guddat, L.W., Wang, Q., Lou, Zh., and Rao, Z., Science, 2020, vol. 368, p. 779. https://doi.org/10.1126/science.abb7498
Kirsch, K., Zeke, A., Toke, O., Sok, P., Sethi, A., Sebo, A., Kumar, G.S., Egri, P., Poti, A.L., Gooley, P., Peti, W., Bento, I., Alexa, A., and Remeny, A., Nat. Commun., 2020, vol. 11, p. 5769. https://doi.org/10.1038/s41467-020-19582-3
Funding
This work was supported by ongoing institutional funding. No additional grants to carry out or direct this particular research were obtained.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Translated from Zhurnal Organicheskoi Khimii, 2023, Vol. 59, No. 9, pp. 1179–1192 https://doi.org/10.31857/S0514749223090082.
Publisher's Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Harutyunyan, A.A., Sumbatyan, A.S., Hambardzumyan, A.A. et al. Synthesis, Molecular Docking, and Biological Activity of Antimetabolites Based on Uracils and 5-Substituted 2,6-Dimethylpyrimidin-4(3H)-ones. Russ J Org Chem 59, 1511–1522 (2023). https://doi.org/10.1134/S1070428023090087
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070428023090087
Keywords:
- 5-substituted 2,6-dimethylpyrimidin-4(3H)-ones
- 5-substituted 2-[(E)-2-arylethenyl]-6-methylpyrimidin-4(3H)-ones
- 5-(4-fluorobenzyl)-2,6-dimethylpyrimidin-4(3H)-one
- 5-(4-fluorobenzyl)-2,6-bis[(E)-2-(4-fluorophenyl)ethenyl]pyrimidin-4(3H)-one
- uracil
- 5-halouracils
- 3-(chloromethyl)-4-methoxybenzaldehyde
- N-alkylation
- 1-(5-{(E)-2-[5-(butyl
- benzyl
- 4-fluorobenzyl)-4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]ethenyl}-2-methoxybenzyl)pyrimidin-
- -5-fluoropyrimidine-
- 5-bromopyrimidine)-2,4(1H,3H)-diones
- molecular docking
- biological activity